Importance of drug transporters in pharmacokinetics and drug safety

被引：6
|
作者：
Ward, Peter [1 ]
机构：
[1] Johnson & Johnson Pharmaceut Res & Dev LLC, DMPK Dept, San Diego, CA 92121 USA
来源：
TOXICOLOGY MECHANISMS AND METHODS | 2008年 / 18卷 / 01期
关键词：
transporters; drug-drug interactions; drug elimination; toxicity; pharmacology; pharmacokinetics; P-glycoprotein;
D O I：
10.1080/15376510701795306
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
The exact role of transporters in the absorption, distribution, and excretion (ADE) of drugs is still being elucidated; however, current evidence suggests that their role in these processes may be significant. In this review, the role of transporters in the ADE, pharmacology, toxicology, and clinical drug-drug interactions (DDIs) of drugs will be discussed. The current biological tools to assess this role and practical perspectives for the utilization of knowledge about drug transporters to drug discovery and development will also be discussed. Currently, regulatory agencies are focusing on these potential transporter-mediated DDIs. Therefore, guidance and caution on the investigation of these DDIs will be given.
引用
收藏
页码：1 / 10
页数：10
相关论文
共 50 条
  • [31] Involvement of Organic Anion Transporters in the Pharmacokinetics and Drug Interaction of Rosmarinic Acid
    Kang, Yun Ju
    Lee, Chul Haeng
    Park, Soo-Jin
    Lee, Hye Suk
    Choi, Min-Koo
    Song, Im-Sook
    PHARMACEUTICS, 2021, 13 (01) : 1 - 17
  • [32] ABC Transporters: Role in Modulation of Drug Pharmacokinetics and in Physiopathology and Therapeutic Perspectives
    Van Bambeke, Francoise
    CURRENT DRUG TARGETS, 2011, 12 (05) : 598 - 599
  • [33] Interactions of janus kinase inhibitors with drug transporters and consequences for pharmacokinetics and toxicity
    Alim, Karima
    Bruyere, Arnaud
    Lescoat, Alain
    Jouan, Elodie
    Lecureur, Valerie
    Le Vee, Marc
    Fardel, Olivier
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2021, 17 (03) : 259 - 271
  • [34] Renal Drug Transporters and Drug Interactions
    Ivanyuk, Anton
    Livio, Francoise
    Biollaz, Jerome
    Buclin, Thierry
    CLINICAL PHARMACOKINETICS, 2017, 56 (08) : 825 - 892
  • [35] Renal Drug Transporters and Drug Interactions
    Anton Ivanyuk
    Françoise Livio
    Jérôme Biollaz
    Thierry Buclin
    Clinical Pharmacokinetics, 2017, 56 : 825 - 892
  • [36] Enantioselective Drug Recognition by Drug Transporters
    Uwai, Yuichi
    MOLECULES, 2018, 23 (12):
  • [37] Drug Transporters in Drug Efficacy and Toxicity
    DeGorter, M. K.
    Xia, C. Q.
    Yang, J. J.
    Kim, R. B.
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 52, 2012, 52 : 249 - 273
  • [38] Renal drug transporters and their significance in drug–drug interactions
    Jia Yin
    Joanne Wang
    ActaPharmaceuticaSinicaB, 2016, 6 (05) : 363 - 373
  • [39] Pharmacokinetics, metabolism and drug safety: An industry point of view
    Benichou, C
    THERAPIE, 1996, 51 (05): : 487 - 488
  • [40] Safety of statins - Focus on clinical pharmacokinetics and drug interactions
    Bellosta, S
    Paoletti, R
    Corsini, A
    CIRCULATION, 2004, 109 (23) : 50 - 57
12345